Multiple Manufacturers

XIPERE

Manufacturer:

Multiple Manufacturers

Xipere HCPCS:

J3299

HCPCS Code Descriptor:

Injection, triamcinolone acetonide (xipere), 1 mg

Category:

J Code

Xipere NDCs:

24208-0040-40, 71565-0040-01

Primary Type:

Opthalmic

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intraocular

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

71565-0040-01

About Xipere:

XIPERE is an Opthalmic drug manufactured by Bausch Health and administered via the Intraocular route of administration. The J Code: J3299 is aligned to the drug XIPERE.

ACCESS PRICING AND MORE BY REGISTERING

J3299 Added Date:

July 1, 2022

J3299 Effective Date:

July 1, 2022

J3299 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Xipere billing and coding information.
Xipere patient assistance information can be found through The Focus On Access Program at the URL: https://www.bauschretinarx.com/focusonaccess/
XIPERE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for XIPERE. Please check back in a few weeks.